Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Subcutaneous Campath-1H in Fludarabine-Refractory CLL

NCT00274976 is registered in ClinicalTrials.gov with German CLL Study Group as lead sponsor.

NCT NCT00274976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00274976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Subcutaneous Campath-1H in Fludarabine-Refractory CLL
Lead sponsor
German CLL Study Group
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2002
Completion date
August 31, 2009
Enrollment
Not reported
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia